Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 2
1978 2
1979 2
1980 3
1981 2
1982 2
1983 3
1984 3
1985 4
1987 1
1988 4
1989 2
1990 6
1991 5
1992 3
1993 2
1994 5
1995 7
1996 8
1997 11
1998 12
1999 11
2000 8
2001 14
2002 11
2003 11
2004 13
2005 10
2006 14
2007 17
2008 14
2009 18
2010 26
2011 19
2012 26
2013 19
2014 23
2015 23
2016 19
2017 22
2018 19
2019 35
2020 31
2021 43
2022 36
2023 35
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

555 results

Results by year

Filters applied: . Clear all
Page 1
Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms.
McFadden DG, Sadow PM. McFadden DG, et al. Front Endocrinol (Lausanne). 2021 Jun 10;12:696386. doi: 10.3389/fendo.2021.696386. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34177816 Free PMC article. Review.
Diagnostic specificity, which has incorporated a sharp increase in molecular genetic studies of thyroid tumor subtypes and the integration of molecular testing into preoperative management protocols, continues to be challenged by Hurthle cell neoplasia. ...
Diagnostic specificity, which has incorporated a sharp increase in molecular genetic studies of thyroid tumor subtypes and the …
TERT promoter mutations in thyroid cancer.
Liu R, Xing M. Liu R, et al. Endocr Relat Cancer. 2016 Mar;23(3):R143-55. doi: 10.1530/ERC-15-0533. Epub 2016 Jan 5. Endocr Relat Cancer. 2016. PMID: 26733501 Free PMC article. Review.
TERT C228T is far more common than TERT C250T and their collective prevalence is, on average, 0, 11.3, 17.1, 43.2 and 40.1% in benign thyroid tumors, papillary thyroid cancer (PTC), follicular thyroid cancer, poorly differentiated thyroid cancer and anaplastic thyroid cancer, res …
TERT C228T is far more common than TERT C250T and their collective prevalence is, on average, 0, 11.3, 17.1, 43.2 and 40.1% in benign thyroi …
Aspectos fundamentales del nódulo tiroideo y el cáncer bien diferenciado de tiroides para los médicos general y familiar.
Gallegos-Hernández JF. Gallegos-Hernández JF. Gac Med Mex. 2019;155(6):619-623. doi: 10.24875/GMM.19005072. Gac Med Mex. 2019. PMID: 31787768 Free article. Review.
Not all thyroid nodules require the same approach, and not all nodules are associated with cancer and neither should they be removed. The bases for a proper diagnosis of a thyroid tumor are patient history, physical examination and ultrasound. ...This article explai …
Not all thyroid nodules require the same approach, and not all nodules are associated with cancer and neither should they be removed. The ba …
Molecular Chaperones and Thyroid Cancer.
Paladino L, Vitale AM, Santonocito R, Pitruzzella A, Cipolla C, Graceffa G, Bucchieri F, Conway de Macario E, Macario AJL, Rappa F. Paladino L, et al. Int J Mol Sci. 2021 Apr 18;22(8):4196. doi: 10.3390/ijms22084196. Int J Mol Sci. 2021. PMID: 33919591 Free PMC article. Review.
The chaperones belonging to the families of the small heat-shock proteins Hsp70 and Hsp90 and the chaperonin of Group I, Hsp60, have been quantified mostly by immunohistochemistry and Western blot in tumor and normal control tissues and in extracellular vesicles. Distinctive diff …
The chaperones belonging to the families of the small heat-shock proteins Hsp70 and Hsp90 and the chaperonin of Group I, Hsp60, have been qu …
Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms.
Crescenzi A, Baloch Z. Crescenzi A, et al. Front Endocrinol (Lausanne). 2023 May 31;14:1198099. doi: 10.3389/fendo.2023.1198099. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37324272 Free PMC article. Review.
In addition, immunohistochemistry has served to implement changes in the current thyroid tumor classification scheme. It is prudent to perform a panel of immunostains, and the immunoprofile should be interpreted in light of the cytologic and architectural features. …
In addition, immunohistochemistry has served to implement changes in the current thyroid tumor classification scheme. It is pr …
The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication.
MacDonald L, Jenkins J, Purvis G, Lee J, Franco AT. MacDonald L, et al. Horm Cancer. 2020 Oct;11(5-6):205-217. doi: 10.1007/s12672-020-00390-6. Epub 2020 Jun 17. Horm Cancer. 2020. PMID: 32548798 Free PMC article. Review.
Here we review the current state of what is known regarding the thyroid tumor microenvironment and how these factors may contribute to thyroid tumor pathogenesis. Study of the tumor microenvironment within thyroid cancer is a relatively new field, and …
Here we review the current state of what is known regarding the thyroid tumor microenvironment and how these factors may contr …
Thyroid cancer under the scope of emerging technologies.
Tarabichi M, Demetter P, Craciun L, Maenhaut C, Detours V. Tarabichi M, et al. Mol Cell Endocrinol. 2022 Feb 5;541:111491. doi: 10.1016/j.mce.2021.111491. Epub 2021 Nov 2. Mol Cell Endocrinol. 2022. PMID: 34740746 Review.
Transcriptomics will gain cellular and spatial resolution providing a full account of intra-tumor heterogeneity and opening a window on the microenvironment supporting thyroid tumor growth. Artificial intelligence will set morphological analysis on an objective quan …
Transcriptomics will gain cellular and spatial resolution providing a full account of intra-tumor heterogeneity and opening a window on the …
Assessment and Management of Thyroid Disease in Children.
Dimachkieh AL, Kazahaya K, Chelius DC Jr. Dimachkieh AL, et al. Otolaryngol Clin North Am. 2019 Oct;52(5):957-967. doi: 10.1016/j.otc.2019.06.009. Epub 2019 Jul 26. Otolaryngol Clin North Am. 2019. PMID: 31353140 Review.
555 results